Naprod Life Sciences (Naprod) announced today the successful renewal of its European Union Goods Manufacturing Practices (EU-GMP) certification for its manufacturing facility in Palghar. The approval marks a significant milestone for Naprod in its journey of global leadership. The audit was conducted in December 2023 by The National Institute of Pharmacy and Nutrition (OGYÉI), Hungary.
Speaking on the development, Mr. Mohan Jain, Managing Director at Naprod Life Sciences said, “The EU GMP certification for our facility in Palghar is a testament to our consistent efforts to comply with the highest quality standards. We are committed to being compliant and supplying quality products to our customers and patients across the globe.”
The EU-GMP certification highlights the Palghar facility’s capabilities to ensure consistent and controlled production in accordance with the EU’s quality standards. The facility produces a wide range of formulations, liquid and lyophilised injectable products, with a special focus on oncology, anaesthetics and other therapy segments.
